Johnson, Katherine M; Kines, Rhonda C; Roberts, Jeffrey N et al. (2009) Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83:2067-74 |
Roberts, Jeffrey N; Buck, Christopher B; Thompson, Cynthia D et al. (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13:857-61 |
Day, Patricia M; Thompson, Cynthia D; Buck, Christopher B et al. (2007) Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition. J Virol 81:8784-92 |
Hildesheim, Allan; Herrero, Rolando; Wacholder, Sholom et al. (2007) Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA 298:743-53 |
Lowy, Douglas R; Schiller, John T (2006) Prophylactic human papillomavirus vaccines. J Clin Invest 116:1167-73 |
Buck, Christopher B; Thompson, Cynthia D; Roberts, Jeffrey N et al. (2006) Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2:e69 |
Richards, Rebecca M; Lowy, Douglas R; Schiller, John T et al. (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Natl Acad Sci U S A 103:1522-7 |
Buck, Christopher B; Day, Patricia M; Thompson, Cynthia D et al. (2006) Human alpha-defensins block papillomavirus infection. Proc Natl Acad Sci U S A 103:1516-21 |
Nardelli-Haefliger, Denise; Lurati, Floriana; Wirthner, Daniel et al. (2005) Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine. Vaccine 23:3634-41 |
Buck, Christopher B; Thompson, Cynthia D; Pang, Yuk-Ying S et al. (2005) Maturation of papillomavirus capsids. J Virol 79:2839-46 |
Showing the most recent 10 out of 25 publications